The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) belongs to the group of chemotherapeutic ingredients, which specifically affects various tumor cells without targeting the normal cells (1). The gene discussed is TNFSF10; the disease is neoplasm.